Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Life (Basel, Switzerland)|October 26, 2024
Is Thrombectomy Effective for Large Vessel Occlusion Stroke Patients with Mild Symptoms? Meta-Analysis and Trial Sequential AnalysisKuan-Chih Chen, Te-Wei Li, Ji-Kuan Huang, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort StudyAnna Blyzniuk, Po-Huang Chen, Wei-Cheng Chang, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2025
Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysisYu-Han Chen, Andrea Yue-En Sun, Karishma Narain, et al.
Drug and Alcohol Dependence|August 3, 2026
Cannabis use and cardiovascular, renal, and mortality outcomes in patients with type 2 diabetes receiving GLP-1 receptor agonists: A propensity score-matched cohort studyAseel Salameh, Tsung-Ying Yu, Wei-Cheng Chang, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-AnalysisYu-Han Chen, Lindsay Fogel, Andrea Yue-En Sun, et al.
Diagnostics (Basel, Switzerland)|December 11, 2025
Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030Yu-Han Chen, Lindsay Fogel, Andrea Yue-En Sun, et al.
JCO Oncology Practice|December 9, 2025
Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety OutcomesRen-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen, et al.
JCO Oncology Practice|May 6, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung CancerPo-Huang Chen, Hong-Jie Jhou, Wei-Cheng Chang, et al.
The Cochrane Database of Systematic Reviews|May 14, 2025
Total neoadjuvant therapy for locally advanced rectal cancerSophie Mueller, Yung-Shuo Kao, Carolin Kastner, et al.
JMIR Medical Informatics|July 25, 2024
Prediction of In-Hospital Cardiac Arrest in the Intensive Care Unit: Machine Learning-Based Multimodal ApproachHsin-Ying Lee, Po-Chih Kuo, Frank Qian, et al.
Pageof 7